科济药业-B(02171.HK)拟3月6日举行董事会会议以审批年度业绩
Group 1 - The company Kintor Pharmaceutical Co., Ltd. (02171.HK) announced that its board meeting is scheduled for March 6, 2026, to consider and approve the full-year results for the fiscal year ending December 31, 2025, along with other matters [1]